WOLFGANG WINKELMAYER to United States Food and Drug Administration
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about United States Food and Drug Administration.
Connection Strength
0.557
-
Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting. J Am Soc Nephrol. 2011 Jan; 22(1):1-2.
Score: 0.346
-
Fostering innovation, advancing patient safety: the kidney health initiative. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1609-17.
Score: 0.103
-
On the relative safety of intravenous iron formulations: new answers, new questions. Am J Hematol. 2010 Sep; 85(9):643-4.
Score: 0.085
-
The prevalence and cost of unapproved uses of top-selling orphan drugs. PLoS One. 2012; 7(2):e31894.
Score: 0.023